CPN co-chairs, Hugh Middleton and Joanna Moncrieff, went to meet Luciana Berger MP (the shadow minister for Mental Health) to convey the importance of a Critical Psychiatry perspective in developing

A recent meta-analysis of antipsychotic drug treatment for people with ‘treatment refractory schizophrenia’ suggests clozapine may not be better than other antipsychotics. Clozapine has been the mainstay of treatment for

Suicides in the Unites States have reached a 30-year high. The steepest rise is in the middle-aged. The rate of suicide in women rose more than in men, but male

A recent spot check by the Care Quality Commission (CQC) found that Southern Health NHS Mental Health Trust, previously criticised for its inadequate investigations of serious incidents and deaths in

On Saturday May 16, there will be demonstrations against shock treatment in many cities around the world, currently including 21 in 16 American states, plus 2 each in England and

Since the 1st January 2015 drug companies in the United Kingdom have begun recording any payments they make to doctors for a range of services such as lectures or chairing

The BMJ has been told that Committees of NICE are being encouraged to be more favourable to the drug and device industries. BMJ 2014: 349:g6387

Psychosis and schizophrenia in adults: quality standard consultation The draft NICE quality standard for psychosis and schizophrenia in adults was available for consultation. The consultation period ended at 5pm on

CEP exists to communicate the evidence of the damaging effects of psychiatric drugs and treatments in the UK to the people and institutions that can make a difference. This evidence